The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders
Open accessAbstract
. Curcumin is widely used as a dietary spice and a topical medication for the treatment of inflammatory disorders in Asia. This compound also possesses remarkable anti-inflammatory and neuroprotective effects with the ability to pass from the blood brain barrier. Based on several pharmacological activities of curcumin, it has been introduced as an ideal candidate for different neurological disorders. Despite the pleiotropic activities of curcumin, poor solubility, rapid clearance and low stability have limited its clinical application. In recent years, nano-based drug delivery system has effectively improved the aqueous solubility and bioavailability of curcumin. In this review article, the effects of curcumin nanoparticles and their possible mechanism/s of action has been elucidated in various central nervous system (CNS)-related diseases including Parkinson's disease, Huntington disease, Alzheimer's disease, Multiple sclerosis, epilepsy and Amyotrophic Lateral Sclerosis. Furthermore, recent evidences about administration of nano-curcumin in the clinical trial phase have been described in the present review article.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Maiti, P., Paladugu, L., & Dunbar, G. L. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0406-3 · Cited by 88
RetractedAhmad, N., Ahmad, I., Umar, S., Iqbal, Z., Samim, M., & Ahmad, F. J. (2014) · Drug Delivery · doi:10.3109/10717544.2014.941076 · Cited by 70
RetractedBioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543 · cited 2×
“5,17,28 Accordingly over the last decades, numerous nanoformulation-based strategies have been undertaken to improve the properties of curcumin in in vitro, in vivo, and pre-clinical settings.”
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
International Journal of Nanomedicine
(2020) · International Journal of Nanomedicine · doi:10.2147/ijn · Cited by 2,747
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
CURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,647
Wnt signalling regulates adult hippocampal neurogenesis
Lie, D.-C., Colamarino, S. A., Song, H.-J., Désiré, L., Mira, H., Consiglio, A., Lein, E. S., Jessberger, S., Lansford, H., Dearie, A. R., et al. (2005) · Nature · doi:10.1038/nature04108 · Cited by 1,518
ANTIOXIDANT AND ANTI-INFLAMMATORY PROPERTIES OF CURCUMIN
Menon, V. P., & Sudheer, A. R. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_3 · Cited by 1,392
Inflammation in neurodegenerative diseases
Amor, S., Puentes, F., Baker, D., & Van Der Valk, P. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03225.x · Cited by 1,355
A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin
Zorofchian Moghadamtousi, S., Abdul Kadir, H., Hassandarvish, P., Tajik, H., Abubakar, S., & Zandi, K. (2014) · BioMed Research International · doi:10.1155/2014/186864 · Cited by 1,251
Neurodegenerative diseases and oxidative stress
Emerit, J., Edeas, M., & Bricaire, F. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.11.004 · Cited by 1,031
Naksuriya, O., Okonogi, S., Schiffelers, R. M., & Hennink, W. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.090 · Cited by 841
Role of Oxidative Stress in Parkinson's Disease
Hwang, O. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.11 · Cited by 835
Du, C., Liu, C., Kang, J., Zhao, G., Ye, Z., Huang, S., Li, Z., Wu, Z., & Pei, G. (2009) · Nature Immunology · doi:10.1038/ni.1798 · Cited by 811
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
Henchcliffe, C., & Beal, M. F. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0924 · Cited by 783
Curcumin nanoformulations: a future nanomedicine for cancer
Yallapu, M. M., Jaggi, M., & Chauhan, S. C. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.09.009 · Cited by 751
Mitochondrial Defects and Oxidative Stress in Alzheimer Disease and Parkinson Disease
Yan, M. H., Wang, X., & Zhu, X. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.11.014 · Cited by 718
Amyloid diseases: Abnormal protein aggregation in neurodegeneration
Koo, E. H., Lansbury, P. T., & Kelly, J. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.9989 · Cited by 693
Potential of solid lipid nanoparticles in brain targeting.
Kaur, I. P., Bhandari, R., Bhandari, S., & Kakkar, V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.018 · Cited by 615
Tiwari, S. K., Agarwal, S., Seth, B., Yadav, A., Nair, S., Bhatnagar, P., Karmakar, M., Kumari, M., Chauhan, L. K. S., Patel, D. K., et al. (2014) · ACS Nano · doi:10.1021/nn405077y · Cited by 558
Neuroprotective effects of curcumin
Cole, G. M., Teter, B., & Frautschy, S. A. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_8 · Cited by 516
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
Baum, L., & Ng, A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6403 · Cited by 483
Chapel, A., Bertho, J. M., Bensidhoum, M., Fouillard, L., Young, R. G., Frick, J., Demarquay, C., Cuvelier, F., Mathieu, E., Trompier, F., et al. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.452 · Cited by 460
REVIEW: Curcumin and Alzheimer’s disease
Hamaguchi, T., Ono, K., & Yamada, M. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00147.x · Cited by 450
Thiyagarajan, M., & Sharma, S. S. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.06.042 · Cited by 416
Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer's disease
Roney, C., Kulkarni, P., Arora, V., Antich, P., Bonte, F., Wu, A., Mallikarjuana, N. N., Manohar, S., Liang, H.-F., Kulkarni, A. R., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.024 · Cited by 406
Therapeutic Applications of Curcumin Nanoformulations
Yallapu, M. M., Nagesh, P. K. B., Jaggi, M., & Chauhan, S. C. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9811-z · Cited by 392
Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis
Jadidi‐Niaragh, F., & Mirshafiey, A. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02536.x · Cited by 384
Patterns of gliosis in alzheimer's disease and aging cerebrum
Beach, T. G., Walker, R., & McGeer, E. G. (1989) · Glia · doi:10.1002/glia.440020605 · Cited by 336
Clinical toxicities of nanocarrier systems.
Vega-Villa, K. R., Takemoto, J. K., Yáñez, J. A., Remsberg, C. M., Forrest, M. L., & Davies, N. M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.007 · Cited by 325
Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease
B. Mythri, R., & M. Srinivas Bharath, M. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212798918995 · Cited by 323
Cheng, K. K., Yeung, C. F., Ho, S. W., Chow, S. F., Chow, A. H. L., & Baum, L. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9444-4 · Cited by 314
Curcumin in inflammatory diseases
Shehzad, A., Rehman, G., & Lee, Y. S. (2013) · BioFactors · doi:10.1002/biof.1066 · Cited by 311
Anti-inflammatory and irritant activities of curcumin analogues in rats
Mukhopadhyay, A., Basu, N., Ghatak, N., & Gujral, P. K. (1982) · Agents and Actions · doi:10.1007/bf01965935 · Cited by 304
The Mechanisms of Action of Curcumin in Alzheimer’s Disease
Tang, M., & Taghibiglou, C. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170188 · Cited by 304
Nanotechnology-Applied Curcumin for Different Diseases Therapy
Ghalandarlaki, N., Alizadeh, A. M., & Ashkani-Esfahani, S. (2014) · BioMed Research International · doi:10.1155/2014/394264 · Cited by 288
Use of Ginseng in Medicine With Emphasis on Neurodegenerative Disorders
Radad, K., Gille, G., Liu, L., & Rausch, W.-D. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj05010x · Cited by 265
Fan, S., Zheng, Y., Liu, X., Fang, W., Chen, X., Liao, W., Jing, X., Lei, M., Tao, E., Ma, Q., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1461955 · Cited by 258
The role of regulatory T cells in multiple sclerosis
Zozulya, A. L., & Wiendl, H. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0832 · Cited by 240
Maiti, P., & Dunbar, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061637 · Cited by 233
Th17 Cells and Autoimmune Encephalomyelitis (EAE/MS)
Aranami, T., & Yamamura, T. (2008) · Allergology International · doi:10.2332/allergolint.r-07-159 · Cited by 218
Huo, X., Zhang, Y., Jin, X., Li, Y., & Zhang, L. (2019) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2018.11.008 · Cited by 211
Sandhir, R., Yadav, A., Mehrotra, A., Sunkaria, A., Singh, A., & Sharma, S. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8261-y · Cited by 204
Curcumin Nanomedicine: A Road to Cancer Therapeutics
M. Yallapu, M., Jaggi, M., & C. Chauhan, S. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805289219 · Cited by 191
Mohajeri, M., Sadeghizadeh, M., Najafi, F., & Javan, M. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.013 · Cited by 184
Barbara, R., Belletti, D., Pederzoli, F., Masoni, M., Keller, J., Ballestrazzi, A., Vandelli, M. A., Tosi, G., & Grabrucker, A. M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.015 · Cited by 180
Xie, L., Li, X.-K., Funeshima-Fuji, N., Kimura, H., Matsumoto, Y., Isaka, Y., & Takahara, S. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.01.025 · Cited by 179
Zhang, N., Yan, F., Liang, X., Wu, M., Shen, Y., Chen, M., Xu, Y., Zou, G., Jiang, P., Tang, C., et al. (2018) · Theranostics · doi:10.7150/thno.23734 · Cited by 178
Meng, F., Asghar, S., Gao, S., Su, Z., Song, J., Huo, M., Meng, W., Ping, Q., & Xiao, Y. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2015.06.025 · Cited by 176
Huang, N., Lu, S., Liu, X.-G., Zhu, J., Wang, Y.-J., & Liu, R.-T. (2017) · Oncotarget · doi:10.18632/oncotarget.20944 · Cited by 170
Kundu, P., Das, M., Tripathy, K., & Sahoo, S. K. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00207 · Cited by 162
de Girolamo, L., Lucarelli, E., Alessandri, G., Antonietta Avanzini, M., Ester Bernardo, M., Biagi, E., Teresa Brini, A., D’Amico, G., Fagioli, F., Ferrero, I., et al. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319130015 · Cited by 161
Moustapha, A., Pérétout, P., Rainey, N., Sureau, F., Geze, M., Petit, J.-M., Dewailly, E., Slomianny, C., & Petit, P. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.17 · Cited by 160
Ahmadi, M., Agah, E., Nafissi, S., Jaafari, M. R., Harirchian, M. H., Sarraf, P., Faghihi‐Kashani, S., Hosseini, S. J., Ghoreishi, A., Aghamollaii, V., et al. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0606-7 · Cited by 152
Renjie, W., & Haiqian, L. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.003 · Cited by 143
Dende, C., Meena, J., Nagarajan, P., Nagaraj, V. A., Panda, A. K., & Padmanaban, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-10672-9 · Cited by 138
Ganesan, P., Ko, H.-M., Kim, I., & Choi, D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s93918 · Cited by 121
Bollimpelli, V. S., Kumar, P., Kumari, S., & Kondapi, A. K. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.01.006 · Cited by 121
Curcumin has bright prospects for the treatment of multiple sclerosis
Xie, L., Li, X., & Takahara, S. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.08.013 · Cited by 118
Szymusiak, M., Hu, X., León-Plata, P., Ciupinski, P., Wang, Z. J., & Liu, Y. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.07.027 · Cited by 110
NF-κB, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis
Yan, J., & Greer, J. M. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708787122941 · Cited by 106
Hashemian, M., Anissian, D., Ghasemi‐Kasman, M., Akbari, A., Khalili-Fomeshi, M., Ghasemi, S., Ahmadi, F., Moghadamnia, A. A., & Ebrahimpour, A. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.025 · Cited by 106
Self-citationHuang, H., Tang, D., Xu, K., & Jiang, Z.-F. (2013) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2013.848891 · Cited by 104
Dolati, S., Maleki, L. A., Ahmadi, M., Marofi, F., Babaloo, Z., Ayramloo, H., Jafarisavari, Z., Oskouei, H. O., Afkham, A., Younesi, V., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26301 · Cited by 104
Dolati, S., Ahmadi, M., Maleki, L. A., Nikmaram, A., Marofi, F., Rikhtegar, R., Ayromlou, H., & Yousefi, M. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.05.008 · Cited by 103
Wang, X.-S., Zhang, Z., Zhang, M.-M., Sun, M.-X., Wang, W.-W., & Xie, C.-L. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1922-x · Cited by 100
MicroRNA dysregulation in multiple sclerosis
de Faria, O., Moore, C. S., Kennedy, T. E., Antel, J. P., Bar‐Or, A., & Dhaunchak, A. S. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2012.00311 · Cited by 97
Th17 cells in autoimmune demyelinating disease
Segal, B. M. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0186-z · Cited by 95
Siddique, Y. H., Naz, F., & Jyoti, S. (2014) · BioMed Research International · doi:10.1155/2014/606928 · Cited by 93
Shi, S., Liang, D., Chen, Y., Xie, Y., Wang, Y., Wang, L., Wang, Z., & Qiao, Z. (2015) · European Journal of Immunology · doi:10.1002/eji.201545855 · Cited by 93
Agarwal, N. B., Jain, S., Nagpal, D., Agarwal, N. K., Mediratta, P. K., & Sharma, K. K. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.01002.x · Cited by 79
Tripodo, G., Chlapanidas, T., Perteghella, S., Vigani, B., Mandracchia, D., Trapani, A., Galuzzi, M., Tosca, M. C., Antonioli, B., Gaetani, P., et al. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.11.034 · Cited by 79
Siddique, Y. H., Khan, W., Singh, B. R., & Naqvi, A. H. (2013) · ISRN Pharmacology · doi:10.1155/2013/794582 · Cited by 79
Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis
Dolati, S., Ahmadi, M., Rikhtegar, R., Babaloo, Z., Ayromlou, H., Maleki, L. A., Nouri, M., & Yousefi, M. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.05.018 · Cited by 77
Drion, C. M., van Scheppingen, J., Arena, A., Geijtenbeek, K. W., Kooijman, L., van Vliet, E. A., Aronica, E., & Gorter, J. A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1247-9 · Cited by 76
Sun, L., Liu, B., Lin, Z., Yao, Y., Chen, Y., Li, Y., Chen, J., Yu, D., Tang, Z., Wang, B., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0344-y · Cited by 75
Paka, G. D., Doggui, S., Zaghmi, A., Safar, R., Dao, L. H., Reisch, A., Klymchenko, A. S., Roullin, G., Joubert, O., & Ramassamy, C. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00611 · Cited by 74
Naeimi, R., Safarpour, F., Hashemian, M., Tashakkorian, H., Ahmadian, S. R., Ashrafpour, M., & Ghasemi‐Kasman, M. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.03.018 · Cited by 72
Self-citationAkt as a Victim, Villain and Potential Hero in Parkinson’s Disease Pathophysiology and Treatment
Greene, L. A., Levy, O., & Malagelada, C. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9671-8 · Cited by 71
Bertoncello, K. T., Aguiar, G. P. S., de Oliveira, J. V., & Siebel, A. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-20897-x · Cited by 70
Rostami-Mansoor, S., Hashemian, M., Khalili-Fomeshi, M., Ashrafpour, M., Moghadamnia, A. A., & Ghasemi‐Kasman, M. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.08.010 · Cited by 50
Self-citationAhmadi, F., Ghasemi‐Kasman, M., Ghasemi, S., Tabari, M. G., Pourbagher, R., Kazemi, S., & Alinejad-Mir, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146516 · Cited by 49
Self-citationCurcumin in epilepsy disorders
Dhir, A. (2018) · Phytotherapy Research · doi:10.1002/ptr.6125 · Cited by 43
Zhao, G., Liu, Y., Yi, X., Wang, Y., Qiao, S., Li, Z., Ni, J., & Song, Z. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.02.017 · Cited by 38
Neurodegeneration in Progressive Multiple SclerosisPreprint
Campbell, G. R., & Mahad, D. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028985 · Cited by 30
Mouhieddine, T. H., Itani, M. M., Nokkari, A., Ren, C., Daoud, G., Zeidan, A., Mondello, S., & Kobeissy, F. H. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0505-1 · Cited by 21
Therapeutic Effects of Curcumin on Alzheimer’s Disease
Yao, E. C., & Xue, L. (2014) · Advances in Alzheimer s Disease · doi:10.4236/aad.2014.34014 · Cited by 19
Sookhaklari, R., Geramizadeh, B., Abkar, M., & Moosavi, M. (2019) · Europe PMC (PubMed Central) · doi:10.22038/ajp.2018.11592 · Cited by 16
Cited by
Stohs, S. J., Chen, O., Ray, S. D., Ji, J., Bucci, L. R., & Preuss, H. G. (2020) · Molecules · doi:10.3390/molecules25061397 · Cited by 372
Recent Applications of PLGA in Drug Delivery Systems
Yang, J., Zeng, H., Luo, Y., Chen, Y., Wang, M., Wu, C., & Hu, P. (2024) · Polymers · doi:10.3390/polym16182606 · Cited by 268
Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients
Valizadeh, H., Abdolmohammadi-vahid, S., Danshina, S., Ziya Gencer, M., Ammari, A., Sadeghi, A., Roshangar, L., Aslani, S., Esmaeilzadeh, A., Ghaebi, M., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107088 · Cited by 267
Nanotechnology in the diagnostic and therapy for Alzheimer's disease
Panghal, A., & Flora, S. J. S. (2024) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2024.130559 · Cited by 31
Therapeutic applications of curcumin nanomedicine formulations in cystic fibrosis
Quispe, C., Herrera-Bravo, J., Khan, K., Javed, Z., Semwal, P., Painuli, S., Kamiloglu, S., Martorell, M., Calina, D., & Sharifi-Rad, J. (2022) · Progress in Biomaterials · doi:10.1007/s40204-022-00198-3 · Cited by 26
Metadata
- Authors
- Yavarpour-Bali, H., Ghasemi-Kasman, M., & Pirzadeh, M.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2019-06
- Volume
- Volume 14
- Pages
- 4449-4460
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2952808930
- Cited by
- 364
- References
- 91
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.